In the night of February 20, 2020, the first case of novel coronavirus disease (COVID-19) was
confirmed in the Lombardy Region, Italy. In the week that followed, Lombardy experienced …

Background Understanding public perceptions of government responses to COVID-19 may
foster improved public cooperation. Trust in government and population risk of exposure may …

BackgroundNatural immunity to Streptococcus pneumoniae is thought to be induced by
exposure to S. pneumoniae or cross-reactive antigens. No longitudinal studies of carriage of and …

Importance Solid estimates of the risk of developing symptoms and of progressing to critical
disease in individuals infected with severe acute respiratory syndrome coronavirus 2 (SARS-…

A 23-valent polysaccharide pneumococcal vaccine (PPV) has been available in the UK for
more than 20 years and is currently recommended for use in high-risk groups (HRG) of 2+ …

Background: Researchers increasingly use social contact data to inform models for infectious
disease spread with the aim of guiding effective policies about disease prevention and …

This paper analyses Streptococcus pneumoniae transmission dynamics in households using
longitudinal data on pneumococcal (Pnc) carriage in the United Kingdom. Ten consecutive …

We quantified the probability of developing symptoms (respiratory or fever \geq 37.5 {\deg}C)
and critical disease (requiring intensive care or resulting in death) of SARS-CoV-2 positive …

A live-attenuated vaccine against herpes zoster (HZ) has been approved for use, on the
basis of a large-scale clinical trial that suggests that the vaccine is safe and efficacious. This …

OBJECTIVE: To evaluate the potential impact of various pneumococcal conjugate vaccination
strategies, it is critical to ascertain the pre-vaccination epidemiology and to have a …